NCT03592719

Brief Summary

The purpose of this study is to test a counseling program for Black women at high risk for HIV

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 19, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2019

Completed
Last Updated

December 19, 2020

Status Verified

December 1, 2020

Enrollment Period

1.1 years

First QC Date

July 9, 2018

Last Update Submit

December 16, 2020

Conditions

Keywords

HIV PreventionPrEPBlackAfrican AmericanWomenMotivational InterviewingAt risk for HIV

Outcome Measures

Primary Outcomes (2)

  • Change in Motivation for PrEP

    Motivation to use PrEP will be measured with the Contemplation Ladder and the Readiness Ruler, which assess intention to use PrEP and the perceived importance of using PrEP. The Contemplation Ladder and the Readiness Ruler each have a total score range from 0 to 10. Higher scores on the Contemplation Ladder indicate higher levels of contemplation or consideration about PrEP use. Higher scores on the Readiness Ruler indicate higher perceived importance of starting PrEP.

    Baseline, Up to 6 weeks

  • Change in PrEP uptake

    PrEP uptake will be verified by the participants' providers.

    Baseline, Up to 6 weeks

Secondary Outcomes (2)

  • Change in Knowledge of PrEP

    Baseline, Up to 6 weeks

  • Change in Barriers for PrEP

    Baseline, Up to 6 weeks

Study Arms (2)

MI-PrEP

EXPERIMENTAL

Participants in this arm will receive the manualized two-session intervention entitled "Motivational Interviewing to Increase PrEP Uptake"

Behavioral: Experimental Intervention (MI-PrEP)

Enhanced Treatment as Usual (E-TAU)

ACTIVE COMPARATOR

Participants in this arm will receive two sessions which entail psychoeducation on PrEP.

Behavioral: Enhanced Treatment as Usual (E-TAU)

Interventions

The experimental intervention will consist of two sessions. The first session will involve psycho-education on PrEP and Motivational Interviewing to explore ambivalence about PrEP uptake. The second session will involve Motivational Interviewing and case management to explore barriers to accessing PrEP.

Also known as: Motivational Interviewing to Increase PrEP Uptake (MI-PrEP)
MI-PrEP

Participants assigned to the control condition will receive two sessions, both of which involve psychoeducation on PrEP.

Enhanced Treatment as Usual (E-TAU)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIV-negative
  • Identify as Black and/or African American
  • Age 18 or older
  • Cis-gender Female
  • English speaking
  • Is capable of completing and fully understanding the informed consent process and the study procedures and
  • Meets the Center for Disease Control's indications for PrEP use (17): (a) any sex with opposite sex partners in the past 6 months and (b) not in a monogamous partnership with a recently tested HIV-negative partner or (c) any injection of drugs not prescribed by a clinician in the past 6 months AND (d) at least one of the following: (i) infrequently uses condoms in sex with one/more partners of unknown HIV status (ii) in a sexual relationship with an HIV-positive partner or (iii) any sharing of injection/drug preparation equipment in past 6 months.

You may not qualify if:

  • Not capable of completing/fully understanding the consent process and the study procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami

Miami, Florida, 33136, United States

Location

Study Officials

  • Sannisha K Dale, PhD, EdM

    University of Miami

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Psychology

Study Record Dates

First Submitted

July 9, 2018

First Posted

July 19, 2018

Study Start

October 1, 2018

Primary Completion

November 11, 2019

Study Completion

November 11, 2019

Last Updated

December 19, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations